Back to top

NeoGenomics Resolves DOJ Investigation, Refocuses on Cancer Care

NeoGenomics ( ($NEO) ) just unveiled an update. On June 20, 2026, NeoGenomics finalized a civil settlement with the U.S. Department of Justice, act...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

NeoGenomics, Inc. (NEO)